Scorpi18 | Market Insights
@scorpi18
6.29K
subscribers
5.37K
photos
59
videos
24
files
3.57K
links
Insights and analysis of the global financial market by investment advisor Sergio Shalamov.
Note: This is not an investment advice.
Contact:
@invoyager
Buy ads:
https://telega.io/c/scorpi18
Download Telegram
Join
Scorpi18 | Market Insights
6.29K subscribers
Scorpi18 | Market Insights
💥
🇺🇸
#MRNA
#vaccine
Moderna announces teencove study of its covid-19 vaccine in adolescents meets primary endpoint and plans to submit data to regulators in early june
Scorpi18 | Market Insights
🇺🇸
#MRNA
#vaccine
Moderna may launch the single-shot COVID-19 vaccine in India - RTRS
Scorpi18 | Market Insights
💥
🇺🇸
🇮🇳
#india
#PFE
#BNTX
#JNJ
#MRNA
#vaccine
Vaccines from Pfizer / BioNTech, JNJ, and Moderna prepare for mass-market launch in India
- RTRS
Scorpi18 | Market Insights
🇺🇸
#MRNA
#vaccine
#us
Moderna has filed an application with the FDA for full approval of its Covid vaccine
Scorpi18 | Market Insights
💥
🇺🇸
#MRNA
#TMO
#vaccine
Moderna Announces Agreement With Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna's COVID-19 Vaccine
Scorpi18 | Market Insights
🇺🇸
#MRNA
#vaccine
Moderna
announces
new drug substance production agreement with Lonza in the Netherlands
Scorpi18 | Market Insights
🇺🇸
#MRNA
#vaccine
UNICEF and Moderna a
nnounce
long term agreement to supply vaccine on behalf of the COVAX Facility
Scorpi18 | Market Insights
🌎
#vaccine
#world
#G7
G7 leaders agree to speed up production and supply of coronavirus vaccines around the world
#PFE
#BNTX
#MRNA
#JNJ
#AZN
#MRK
Scorpi18 | Market Insights
🇺🇸
#stocks
#us
#individualinvestors
#privateinvestors
Goldman: Daily volume of US singl stock options trades = Record
Goldman: Individual investors are all over the place in call options on US stocks and has more position on
#TSLA
#AMZN
#NVDA
#GOOGL
#AAPL
#AMD
#FB
#MSFT
#MRNA
Scorpi18 | Market Insights
⚠️
🇨🇳
#vaccine
#pandemic
#china
Chinese vaccines are much less effective than
BioNTech
and
Moderna
jabs.
scientists are urging China to look for alternatives to its Covid-19 vaccines to tackle its Omicron outbreak
.
#BNTX
#MRNA
Scorpi18 | Market Insights
⚡️
🇺🇸
#MRNA
#report
Moderna
Q2 22 Earnings:
- EPS: $5.24 (est $4.54)
- Revenue: $4.75Bln (est $4.02)
- Announces New $3Bln Share Buyback Plan
#buyback
Announces New $3Bln Share Buyback Plan